Cosmos Health Inc COSM 深 滬
等待開盤 05-30 09:30:00 美东时间
0.2507
-0.009
-3.32%
華盛通- 最 高0.264
- 今 開0.264
- 成交量 44.63万股
- 最 低 0.25
- 昨 收 0.2593
- 總市值 1364.52万
- 52周最高 1.32
- 市盈率 靜 --
- 換手率 0.82%
- 52周最低 0.2464
- 委 比 33.33%
- 總股本 5442.85万
- 歷史最高 23.84
- 量 比 0.47
- 振 幅 5.40%
- 歷史最低 0.2464
- 每 手 1
- 風險率 0.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cosmos Health Expects FY29 Adjusted EPS Of $0.73, Revenue Of $200.6M
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced its financial guidance for the 2026–2029
05-26 21:44
BRIEF-Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029
BRIEF-Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029 May 26 (Reuters) - Cosmos Health Inc COSM.O : COSMOS HEALTH RELEASES 2026–2029 GUIDANCE: TARGETING $200M REVENUE, $71M GROSS PROFIT, AND $44M ADJUSTED EBITDA BY 2029 — BUILDING AN INNOVATIVE, HIGH-MARGIN HEALTHCARE PLATFOR
05-26 21:39
Cosmos Health shares are trading lower after the company reported worse-than-expected Q1 financial results.
Cosmos Health shares are trading lower after the company reported worse-than-ex...
05-22 01:28
Cosmos Health Q1 EPS $(0.06) Misses $(0.01) Estimate, Sales $17.928M Miss $21.893M Estimate
Cosmos Health (NASDAQ:COSM) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 500 percent. This is a 100 percent decrease over losses of $(0.03) per share from the
05-21 21:17
Cosmos Health Expects Fort18 To Report More Than $3.2M Incremental Annual U.S. Revenue Over Next 12 To 18 Months
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced it is projecting Fort18™ to generate over $3.2 million in
05-12 02:27
Cosmos Health Projects Cur18 Supplement To Generate $2.5M+ Annual Revenue Within 18-Months
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it is projecting Cur18™ to generate over $2.5 million in
05-01 00:55
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 19.1% to $16.23 during ...
04-25 05:05
Cosmos Health Says Liv18 Liver Supplement Completes Phase 1 Ahead Of Schedule; U.S. Production Begins April 2026 With $5M+ Projected Annual Revenue
Phase 1 complete: product development, packaging, and initial commercial setup finalized ahead of scheduleProduction commencing April 2026: GMP-certified, FDA-registered, UL-audited U.S. manufacturing - mitigating tariff
04-20 22:57
Cosmos Health expects Liv18 to generate over $5 million annual revenue
Cosmos Health expects Liv18 to generate over $5 million annual revenue Cosmos Health forecast Liv18 to generate more than $5 million in annual revenue with gross margin around 75% as it expands in US. Production set to start in April 2026 at US GMP-certified, FDA-registered, UL-audited facilities, s
04-20 22:55
Cosmos Health Q4 Adj. EPS $(0.04), Inline, Sales $19.703M Beat $18.821M Estimate
Cosmos Health (NASDAQ:COSM) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 91.11 percent increase over losses of $(0.45) per share from the same period last year. The
04-15 21:53
